TY - JOUR
T1 - Comorbidity of dementia with amyotrophic lateral sclerosis (ALS): insights from a large multicenter Italian cohort
AU - Trojsi, Francesca
AU - Siciliano, Mattia
AU - Femiano, Cinzia
AU - Santangelo, Gabriella
AU - Lunetta, Christian
AU - Calvo, Andrea
AU - Moglia, Cristina
AU - Marinou, Kalliopi
AU - Ticozzi, Nicola
AU - Drago Ferrante, Gianluca
AU - Scialò, Carlo
AU - Sorarù, Gianni
AU - Conte, Amelia
AU - Falzone, Yuri M.
AU - Tortelli, Rosanna
AU - Russo, Massimo
AU - Sansone, Valeria Ada
AU - Chiò, Adriano
AU - Mora, Gabriele
AU - Poletti, Barbara
AU - Volanti, Paolo
AU - Caponnetto, Claudia
AU - Querin, Giorgia
AU - Sabatelli, Mario
AU - Riva, Nilo
AU - Logroscino, Giancarlo
AU - Messina, Sonia
AU - Fasano, Antonio
AU - Monsurrò, Maria Rosaria
AU - Tedeschi, Gioacchino
AU - Mandrioli, Jessica
PY - 2017
Y1 - 2017
N2 - To assess the association, at diagnosis, between amyotrophic lateral sclerosis (ALS) and dementia in a large cohort of well-characterized Italian patients. We investigated the phenotypic profile of 1638 incident patients with definite, probable or laboratory-supported probable ALS, diagnosed from January 2009 to December 2013 in 13 Italian Referral Centers, located in 10 Italian Regions, and classified in two independent subsamples accounting for presence or not of dementia. The collected ALS features, including survival and other follow-up data, were compared between the two subgroups using a one-way analysis of variance and Chi-square test, as appropriate, logistic regression models and KaplanâMeier survival analysis. Between-subgroup comparisons showed an older age at clinical observation (p = .006), at onset and at diagnosis (p = .002) in demented versus non demented ALS patients. After adjustment for these variables, diagnosis of dementia was significantly associated with higher odds of family history of ALS (p = .001) and frontotemporal dementia (p = .003) and of bulbar onset (p = .004), and lower odds of flail leg phenotype (p = .019) and spinal onset (p = .008). The median survival time was shorter in demented versus non-demented patients, especially in case of classical, bulbar and flail limb phenotypes and both bulbar and spinal onset. Our multicenter study emphasized the importance of an early diagnosis of comorbid dementia in ALS patients, which may have clinical impact and prognostic relevance. Moreover, our results may give further inputs to validation of ALS-specific tools for the screening of cognitive impairment in clinical practice.
AB - To assess the association, at diagnosis, between amyotrophic lateral sclerosis (ALS) and dementia in a large cohort of well-characterized Italian patients. We investigated the phenotypic profile of 1638 incident patients with definite, probable or laboratory-supported probable ALS, diagnosed from January 2009 to December 2013 in 13 Italian Referral Centers, located in 10 Italian Regions, and classified in two independent subsamples accounting for presence or not of dementia. The collected ALS features, including survival and other follow-up data, were compared between the two subgroups using a one-way analysis of variance and Chi-square test, as appropriate, logistic regression models and KaplanâMeier survival analysis. Between-subgroup comparisons showed an older age at clinical observation (p = .006), at onset and at diagnosis (p = .002) in demented versus non demented ALS patients. After adjustment for these variables, diagnosis of dementia was significantly associated with higher odds of family history of ALS (p = .001) and frontotemporal dementia (p = .003) and of bulbar onset (p = .004), and lower odds of flail leg phenotype (p = .019) and spinal onset (p = .008). The median survival time was shorter in demented versus non-demented patients, especially in case of classical, bulbar and flail limb phenotypes and both bulbar and spinal onset. Our multicenter study emphasized the importance of an early diagnosis of comorbid dementia in ALS patients, which may have clinical impact and prognostic relevance. Moreover, our results may give further inputs to validation of ALS-specific tools for the screening of cognitive impairment in clinical practice.
KW - Amyotrophic lateral sclerosis
KW - Clinical phenotype
KW - Dementia
KW - Neurology
KW - Neurology (clinical)
KW - Survival
KW - Amyotrophic lateral sclerosis
KW - Clinical phenotype
KW - Dementia
KW - Neurology
KW - Neurology (clinical)
KW - Survival
UR - http://hdl.handle.net/10807/112005
U2 - 10.1007/s00415-017-8619-4
DO - 10.1007/s00415-017-8619-4
M3 - Article
SN - 0340-5354
VL - 264
SP - 2224
EP - 2231
JO - Journal of Neurology
JF - Journal of Neurology
ER -